Indeed, the inhibition of TRPV1 channels through the antagonist AMG9810 reduces MM cells’ viability by inducing mitochondrial ROS accumulation and affects MM cells’ migration and adhesion by blocking CXCR4/CXCL12 axis. The gene discussed is CXCL12; the disease is Miyoshi myopathy.